Study details
Enrolling now
A Study Evaluating Manual Lymphatic Drainage
University of Florida
NCT IDNCT06327490ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
30
Study length
about 3.7 years
Ages
18–99
Locations
1 site in FL
What this study is about
This trial is testing a new way to do manual lymphatic drainage (MLD) for breast cancer patients. It compares using Indocyanine Green (ICG) to guide the MLD with traditional methods, aiming to see if it's feasible and easy for people to follow.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Indocyanine green
- 2.Undergo ICG-guided manual lymphatic drainage
- 3.Undergo Traditional manual lymphatic drainage
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized (Open Label)
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
indocyanine green
Endpoints
Secondary: Breast cancer related lymphedema symptoms, Health-related quality of life
Body systems
Oncology